CAS 1200133-34-1

VCH-916 

CAS : 1200133-34-1

Formule : C₂₆H₃₆KNO₄S

Degré de pureté : 98%

Masse moléculaire : 497.7316

Ref: IN-DA008TKI

Potassium 5-(cyclohex-1-en-1-yl)-3-(trans-N-(trans-4-methoxycyclohexyl)-4-methylcyclohexane-1-carboxamido)thiophene-2-carboxylate

CAS : 1200133-34-1

Potassium 5-(cyclohex-1-en-1-yl)-3-(trans-N-(trans-4-methoxycyclohexyl)-4-methylcyclohexane-1-carboxamido)thiophene-2-carboxylate

Degré de pureté : 98%

Masse moléculaire : 497.74g/mol

Ref: 54-OR1074807

VCH-916

CAS : 1200133-34-1

VCH-916 is a new nonnucleoside inhibitor of HCV NS5B polymerase.

Formule : C₂₆H₃₆KNO₄S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 497.73

Ref: TM-TQ0122

VCH-916

CAS : 1200133-34-1

VCH-916 is a non-nucleoside NS3 protease inhibitor that blocks the activity of the NS3 protease and prevents the processing of hepatitis C virus (HCV) polyprotein. VCH-916 has been shown to be effective against HCV genotype 1a, which is resistant to most other drugs, as well as genotypes 1b and 3. VCH-916 has been shown to inhibit chronic kidney disease in mice by suppressing the cell function and proliferation of mesangial cells. VCH-916 also inhibits viral replication by preventing the synthesis of viral RNA. This drug potently inhibits a wide range of viruses including HIV, herpes simplex virus type 2 (HSV2), influenza A virus (IAV), and vesicular stomatitis virus (VSV). The pharmacokinetics of this drug have been studied in healthy volunteers and patients with chronic kidney disease.

Formule : C₂₆H₃₆KNO₄S

Degré de pureté : Min. 95%

Masse moléculaire : 497.73 g/mol

Ref: 3D-AYB13334